Dambkowski Carl: insider trades.
Dambkowski Carl reported 7 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($1.5M), across 1 company.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 2
- Companies
- 1
- Name as filed
- Dambkowski Carl
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Apogee Therapeutics, Inc. (APGE) | Officer · Chief Medical Officer | 7 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-03 | Apogee Therapeutics, Inc. | D | 167,123 | — | 0 | Form 4 |
| 2026-09-02 | Apogee Therapeutics, Inc. | D | 1,375 | $135.06 | 167,123 | Form 4 |
| 2026-08-05 | Apogee Therapeutics, Inc. | M | 4,125 | $22.86 | 173,998 | Form 4 |
| 2026-08-05 | Apogee Therapeutics, Inc. | S | 5,500 | $134.17 | 168,498 | Form 4 |
| 2026-07-14 | Apogee Therapeutics, Inc. | G | 8,000 | $0 | 169,873 | Form 4 |
| 2026-07-01 | Apogee Therapeutics, Inc. | S | 5,500 | $132.74 | 177,873 | Form 4 |
| 2026-07-01 | Apogee Therapeutics, Inc. | M | 4,125 | $22.86 | 183,373 | Form 4 |
Questions
What stock did Dambkowski Carl buy or sell?
Dambkowski Carl reported 7 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($1.5M), across 1 company.
Is Dambkowski Carl the same person as other filers with this name?
This page covers SEC CIK 1983476 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/dambkowski-carl-1983476.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.